Tag: biomedical

  • Compression Software for Genomic Analysis Being Designed

    6 July 2015. Engineers at University of Illinois in Urbana and Stanford University in California are tackling the problem of massive data files generated by genomic analyses, an emerging issue as precision medicine harnessing genomics takes hold. A team led by engineering faculty Olgica Milenkovic at Illinois and Tsachy Weissman at Stanford is funded by…

  • Poll: Parents Consider Vaccines Safe, Beneficial

    6 July 2015. A nationwide survey of parents in the U.S. shows the vast majority of parents believe vaccines for children are as safe and beneficial as a year ago, with sizable numbers — from a quarter to a third — saying vaccines’ safety and benefits are increasing. The results were published today by C.S.…

  • Engineered Mosquitoes Sharply Reduce Dengue Carriers

    2 July 2015. A variety of mosquito, engineered to produce offspring that die before maturity, was found to reduce the dengue mosquito population in a city in Brazil by 95 percent, well below the level needed to spread the disease. The team from the biotechnology company Oxitec Ltd. in Abingdon, U.K., with academic and business…

  • Drug Abusers, Smokers More Likely to Use Opioids Long-Term

    1 July 2015. A study by the Mayo Clinic finds people with a history of substance abuse and using tobacco are those most at risk for using opioid pain killers on a continuous basis. The team led by Michael Hooten, an anesthesiologist at Mayo Clinic in Rochester, Minnesota, published its findings in the July issue…

  • Foundation Supporting ALS Pilot Clinical Trials

    1 July 2015. ALS Association is funding pilot studies with patients having amyotrophic lateral sclerosis to confirm biomarkers, or biochemical indicators, that improve responsiveness to therapies. The studies are being conducted by Neuraltus Pharmaceuticals Inc., a biopharmaceutical developer in Palo Alto, California, and University of Washington Medical Center in Seattle. ALS, also known as Lou…

  • Juno, Celgene Partner in $1 Billion Immunotherapy Deal

    30 June 2015. Biotechnology company Juno Therapeutics Inc. and biopharmaceutical developer Celgene Corp. are collaborating on therapies that harness the immune system to treat cancer and autoimmune diseases over the next 10 years. The agreement is expected to bring Juno nearly $1 billion from Celgene in upfront payments and stock purchases. Juno Therapeutics, headquartered in…

  • Patient Registry Started for Rare Genetic Disorder

    29 June 2015. A registry of families with individuals having Sjögren-Larsson syndrome aims to systematically collect data about families’ experiences with the disease and provide a source of participants for clinical trials of therapies. The registry is being formed by the National Organization for Rare Disorders and Sjögren-Larsson Syndrome Network Community. Sjögren-Larsson Syndrome, or SLS,…

  • Novartis Acquires Pain Medication Developer in $200M Deal

    29 June 2015. Global pharmaceutical company Novartis is acquiring Spinifex Pharmaceuticals Inc., a developer of new types of therapies for neuropathic pain. Spinifex reports Novartis is paying $200 million in cash for the company — based in Stamford, Connecticut and Melbourne, Australia — as well as undisclosed future milestone payments. Spinifex Pharmaceuticals develops therapies for…

  • Rare Disease Therapy Company Raises $60 Million in IPO

    26 June 2015. Catabasis Pharmaceuticals Inc., a biotechnology company creating treatments for rare diseases and cholesterol-related disorders, is raising $60 million in its initial public stock offering, trading on the Nasdaq exchange under the symbol CATB. The Cambridge, Massachusetts enterprise yesterday priced its 5 million shares at $12.00, and as of 4:00 pm today is…

  • Point-of-Care Ebola Test Found Accurate in Field Test

    26 June 2015. A commercial point-of-care test detecting Ebola virus in the blood of a patient was shown in a field test in Sierra Leone to be as accurate as tests sent to remote labs for analysis. Results of the study led by Nira Pollock of Harvard Medical School and Boston Children’s Hospital were published…